Nuwellis, Inc. To Announce Third Quarter 2021 Financial Results on November 9, 2021
Nuwellis, Inc. (NASDAQ: NUWE) announced the release date for its third quarter 2021 financial results, set for November 9, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Nuwellis, Inc. (NASDAQ: NUWE) announced the release date for its third quarter 2021 financial results, set for November 9, 2021. The company will also hold a conference call at 9:00 AM ET to discuss these results along with a general business overview. Investors can access the call via the company’s website or by dialing in. As a medical device company, Nuwellis focuses on innovative solutions for patients suffering from fluid overload, primarily through its Aquadex SmartFlow® system.
Positive
- Scheduled financial results announcement for Q3 2021.
- Company's ongoing focus on innovation in medical devices.
Negative
- None.
Details
News Market Reaction – NUWE
The recorded move for NUWE in the trading session of this news was -2.38%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EDEN PRAIRIE, Minn., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), announced today that its third quarter 2021 financial results will be released on Tuesday, November 9, 2021. The company will host a conference call and webcast at 9:00 AM ET, during which management will discuss the company's financial results and provide a general business overview.
To access the live webcast, please visit the Investors page of the Nuwellis website at https://ir.nuwellis.com. Alternatively, you may access the live conference call by dialing (877) 303-9826 (U.S.) or (224) 357-2194 (international) and using conference ID: 1436426. An audio archive of the webcast will be available following the call on the Investors page at https://ir.nuwellis.com.
About Nuwellis
Nuwellis, Inc. (Nasdaq: NUWE) is a medical device company dedicated to transforming the lives of patients suffering from fluid overload through science, collaboration, and innovation. The Company is focused on developing, manufacturing and commercializing the Aquadex SmartFlow® system for ultrafiltration therapy. Nuwellis is headquartered in Minneapolis, MN, with a wholly-owned subsidiary in Ireland.
Investor Contacts:
George Montague
Chief Financial Officer, Nuwellis, Inc.
ir@nuwellis.com
Matt Bacso, CFA
Gilmartin Group LLC
Matt.bacso@gilmartinir.com
Media Contact:
Laurel Hood
Health+Commerce
laurel@healthandcommerce.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.